No shortage on file

YORVIPATH

PENDOPHARM DIVISION OF PHARMASCIENCE INC

Quick answers

Is there a shortage of YORVIPATH in Canada?

No. There is no current shortage of YORVIPATH 420MCG reported to Health Canada. Stock can still vary from one pharmacy to another.

Can I still get this?No shortage reported — confirm local stock with your pharmacy

StatusNo shortage on file

Same-ingredient products on file1 product

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Other Products

YORVIPATH

PENDOPHARM DIVISION OF PHARMASCIENCE INC

168MCG · DIN 02565153

Different strengthSame dosage formSame routeNo current shortage

Compare these two →

DIN

02565188

Strength

420MCG

Dosage Form

Solution

Route

Subcutaneous

Active Ingredient

PALOPEGTERIPARATIDE

See all PALOPEGTERIPARATIDE products →

Compare with another product →

Product Monograph

Official Product Monograph (Health Canada)

View official Health Canada drug record ↗

Shortage History

No shortage or discontinuation reports on file for this product.

Other Products from PENDOPHARM DIVISION OF PHARMASCIENCE INC

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

120MG · DIN 02230434

160MG · DIN 02230435

325MG · DIN 02230436

650MG · DIN 02230437

150MG · DIN 00778338

500UNIT · DIN 00584908